Detection of Circulating Tumor Cells in Blood Using an Optimized Density Gradient Centrifugation

  • Ralf Gertler
  • Robert Rosenberg
  • Katrin Fuehrer
  • Michael Dahm
  • Hjalmar Nekarda
  • Joerg Ruediger Siewert
Part of the Recent Results in Cancer Research book series (RECENTCANCER, volume 162)

Abstract

The aim of the study was to compare the new density gradient centrifugation system OncoQuick with the standard density gradient centrifugation system Ficoll for improved tumor cell enrichment in blood of tumor patients. Evaluation of OncoQuick and Ficoll density gradient centrifugation was performed by flow-cytometry and immunocytochemistry using 10 ml unspiked and tumor cell-spiked blood samples of tumor-free probands. From 10 ml blood, OncoQuick density gradient centrifugation separated a cell fraction which consisted of a mean cell number of 9.5×l04 mononuclear cells compared to 1.8×l07 cells by Ficoll. Density gradient centrifugation of tumor cell-spiked blood samples with OncoQuick and Ficoll led to similar tumor cell recovery rates, between 70% and 90% for both methods. The improved depletion of mononuclear blood cells by OncoQuick simplified further immunocytochemical evaluation of the enriched cell fraction, which could be spun onto 1–2 glass slides by cytocentrifugation. In comparison, the mononuclear cells separated by Ficoll had to be spun onto more than 50 glass slides for complete immunocytochemical evaluation. Consequently, tumor cell density on each cytospin was higher after OncoQuick preparation compared to Ficoll. Density gradient centrifugation with OncoQuick results in higher relative tumor cell enrichment than Ficoll density gradient centrifugation. This simplifies further immunocytochemical tumor cell detection and is a promising tool for the detection of circulating tumor cells in blood of tumor patients.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Bostik PJ, Chatterjee S, Chi DD, Huynh KT, Giuliano AE, Cote R, Hoon DS (1998) Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients. J Clin Oncol 16:2632–2640Google Scholar
  2. 2.
    Jung R, Soondrum K, Krüger W, Neumaier M (2001) Detection of micrometastasis through tissue-specific gene expression: its promise and problems. Rec Res Cancer Res 158:32–39CrossRefGoogle Scholar
  3. 3.
    von Knebel Doeberitz M, Koch M, Weitz J, Herfarth C (2001) Diagnostik und Bedeutung der “Minimal Residual Disease” bei Patienten mit kolorektalem Karzinom. Zentralbl Chir [Suppl 1]:15—19Google Scholar
  4. 4.
    Pantel K, Riethmüller G (1995) Methods for detection of micrometastatic carcinoma cells in bone marrow, blood and lymph nodes. Onkologie 18:394–401CrossRefGoogle Scholar
  5. 5.
    Pantel K, von Knebel Doeberitz M (2000) Detection and clinical relevance of micrometastas-tic cancer cells. Curr Opin Oncol 12:95–101PubMedCrossRefGoogle Scholar
  6. 6.
    Soeth E, Vogel I, Roder C, Juhl H, Marxen J, Kruger U, Henne-Bruns D, Kremer B, Kalthoff H (1997) Comparative analysis of bone marrow and venous blood isolates from gastrointestinal cancer patients for the detection of disseminated tumor cells using reverse transcription PCR. Cancer Res 57:3106–3110PubMedGoogle Scholar
  7. 7.
    Weitz J, Kienle P, Lacroix J, Willeke F, Benner A, Lehnert T, Herfarth C, v. Knebel Doeberitz M (1998) Dissemination of tumor cells in patients undergoing surgery for colorectal cancer. Clin Cancer Res 4:343–348PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2003

Authors and Affiliations

  • Ralf Gertler
    • 1
  • Robert Rosenberg
  • Katrin Fuehrer
  • Michael Dahm
  • Hjalmar Nekarda
  • Joerg Ruediger Siewert
  1. 1.Chirurgische Klinik und PoliklinikKlinikum rechts der Isar der Technischen Universität MünchenMunichGermany

Personalised recommendations